Rybelsus is the brand name for oral semaglutide, a pioneering medication designed for the management of type 2 diabetes. It is the first GLP-1 receptor agonist available in a tablet form, eliminating the need for injections. Rybelsus works by enhancing insulin secretion, suppressing appetite. The study also included researchers from University of Pecs in Hungary. […]
